Log In
Print this Print this

Camtobell, belotecan (CKD-602)

  Manage Alerts
Collapse Summary General Information
Company Chong Kun Dang Pharmaceutical Corp.
DescriptionCamptothecin analogue
Molecular Target Topoisomerase I (TOP1)
Mechanism of ActionTopoisomerase I inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today